dpp4i and glp 1 agonist Could GLP-1 Receptor Agonists Help Prevent Infections in People with Diabetes? A Nationwide Study Says Yes—At Least for the Lungs Feet #ActAgainstAmputation #DiabeticFoot #GLP1RA DPP4 Inhibitors vs GLP-1 Agonists

The information in this blog is subject to change without notice

19 Given the possibility that existing GLP-1 drugs are insufficient for treating Alzheimers and Parkinsons disease, some researchers are studying new versions of GLP-1s designed to solve that exact problem

In addition to helping with weight loss, GLP-1s have been shown to support better overall wellness, including improved blood sugar control, lower risk of heart and kidney disease and relief from joint or sleep-related issues caused by excess weight

Glucagon-like peptide-1 receptor agonist Exendin-4 improves neurological outcomes by attenuating TBI- induced inflammatory responses and MAPK activation in rats

R.ChaiS

Receptor pharmacology studies suggest that tirzepatide engages the hGIPR in a manner similar to GIP but displays biased signaling at the GLP-1R to favor cAMP generation over beta-arrestin recruitment (Figure 2) 4749